Moore HN - Search Results

1

National trends in hospitalization and mortality rates for patients with HIV, HCV, or HIV/HCV coinfection from 1996-2010 in the United States: a cross-sectional study.

Oramasionwu CU, Toliver JC, Johnson TL, Moore HN, Frei CR. Oramasionwu CU, et al. Among authors: moore hn. BMC Infect Dis. 2014 Oct 10;14:536. doi: 10.1186/1471-2334-14-536. BMC Infect Dis. 2014. PMID: 25300638 Free PMC article.

2

Barriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a review.

Oramasionwu CU, Moore HN, Toliver JC. Oramasionwu CU, et al. Among authors: moore hn. AIDS Patient Care STDS. 2014 May;28(5):228-39. doi: 10.1089/apc.2014.0033. Epub 2014 Apr 16. AIDS Patient Care STDS. 2014. PMID: 24738846 Free PMC article. Review.

3

Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.

Moore HN, Mao L, Oramasionwu CU. Moore HN, et al. AIDS Care. 2015;27(12):1443-8. doi: 10.1080/09540121.2015.1109583. Epub 2015 Nov 26. AIDS Care. 2015. PMID: 26608408

4

Dead space in over-the-counter syringes: The implications for HIV and HCV transmission.

Oramasionwu CU, Bailey SC, Moore HN, Oramasionwu CO, Russell AL, Zule WA. Oramasionwu CU, et al. Among authors: moore hn. Int J Drug Policy. 2015 Dec;26(12):1282-4. doi: 10.1016/j.drugpo.2015.08.002. Epub 2015 Aug 13. Int J Drug Policy. 2015. PMID: 26342274 No abstract available.

5

Vaccination of Adults With Cancer: ASCO Guideline.

Kamboj M, Bohlke K, Baptiste DM, Dunleavy K, Fueger A, Jones L, Kelkar AH, Law LY, LeFebvre KB, Ljungman P, Miller ED, Meyer LA, Moore HN, Soares HP, Taplitz RA, Woldetsadik ES, Kohn EC. Kamboj M, et al. Among authors: moore hn. J Clin Oncol. 2024 Mar 18:JCO2400032. doi: 10.1200/JCO.24.00032. Online ahead of print. J Clin Oncol. 2024. PMID: 38498792

6

Toxicity studies of acetoin and 2,3-pentanedione administered by inhalation to Wistar Han [Crl:WI(Han)] rats and B6C3F1/N mice.

National Toxicology Program. National Toxicology Program. Toxic Rep Ser. 2023 Mar;(98):NTP-TOX-98. doi: 10.22427/NTP-TOX-98. Toxic Rep Ser. 2023. PMID: 36999846 Free PMC article.

7

Evaluation of alpelisib-induced hyperglycemia prophylaxis and associated risk factors in PIK3CA-mutated hormone-receptor positive, human epidermal growth factor-2 negative advanced breast cancer.

Burnette SE, Poehlein E, Lee HJ, Force J, Westbrook K, Moore HN. Burnette SE, et al. Among authors: moore hn. Breast Cancer Res Treat. 2023 Jan;197(2):369-376. doi: 10.1007/s10549-022-06798-8. Epub 2022 Nov 21. Breast Cancer Res Treat. 2023. PMID: 36409396

8

Needs assessment for patient-centered education and outcome metrics in robotic surgery.

Moore HN, de Paula TR, Keller DS. Moore HN, et al. Surg Endosc. 2023 May;37(5):3968-3973. doi: 10.1007/s00464-022-09500-7. Epub 2022 Aug 24. Surg Endosc. 2023. PMID: 36002685 Free PMC article.

9

Exocrine pancreatic insufficiency after bariatric surgery: a bariatric surgery center of excellence experience.

Moore HN, Chirco AR, Plescia T, Ahmed S, Jachniewicz B, Rajasekar G, Ali MR, Lyo V. Moore HN, et al. Surg Endosc. 2023 Feb;37(2):1466-1475. doi: 10.1007/s00464-022-09388-3. Epub 2022 Jun 29. Surg Endosc. 2023. PMID: 35768735

10

Sex Differences in Nicotine Enhancement of Conditioned Place Avoidance Driven by Footshock in Male and Female Rats.

Barker AM, Moore HN, Buffalari D. Barker AM, et al. Among authors: moore hn. Nicotine Tob Res. 2022 Oct 17;24(10):1689-1692. doi: 10.1093/ntr/ntac109. Nicotine Tob Res. 2022. PMID: 35439811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page